Aprecia is The 3DP Pharmaceutical Company. Our proprietary, advanced fast-melt dose form innovation, ZipDose Technology, is the first and only 3DP technology platform used in an FDA approved product. Aprecia uses its ZipDose® Technology to create rapidly disintegrating oral dosage forms that are easy to take and easy to administer. Without compression during the 3DP manufacturing process, engineered and coated particles such as taste masking and modified release are possible on large dose products, even those with greater than 1,000mg of active pharmaceutical ingredient. Aprecia’s novel manufacturing approach enables flexibility and freedom to design patient centric medications without traditional formulation barriers.
Aprecia directly owns a patent estate for novel 3DP machines and pharmaceutical 3DP applications. It licenses its exclusive technology platform to pharmaceutical partners as a means to extend product lines, improve patient reach and experience, and address FDA requirements as a pediatric delivery form.
Aprecia seeks to partner with pharmaceutical companies to bring innovative, commercial scale 3DP manufacturing capabilities to their existing product portfolios and research pipelines. Advanced fast melt, high drug load, modified release and combination drugs are just a few of the possibilities our team can explore with you at AAPS PharmSci360. Aprecia is committed to enhancing the patient experience through novel approaches to drug delivery that address partner’s formulation barriers and unmet patient needs.
10901 Kenwood Rd.
Blue Ash, Ohio 45242
Formulation and Delivery